AFP / Alex Edelman
Industrial giant 3M reported higher quarterly
profits as it works to ramp up medical masks amid surging demand for
personal protective equipment due to the coronavirus outbreak
Industrial giant 3M reported rising quarterly profits
Tuesday as it ramps up production of N95 masks while combatting
price-gouging and fraud during the coronavirus outbreak.
The
company manufactures a wide range of products used in myriad industries,
but has become prominent during the COVID-19 outbreak as one of the
only producers of N95 "respirator" masks which can protect against the
virus.
The masks have been an essential item to hospitals on the
front line of the outbreak and have emerged as the object of illicit
practices, price gouging and fraud, with new cases announced by federal
officials in the last day.
3M experienced a 21 percent surge in
sales in its health care business during the first quarter, a key driver
of a 45 percent jump in first-quarter profits to $1.3 billion. Revenues
climbed 2.7 percent to $8.1 billion.
"Even with 3M's accelerated
production, the stark reality is that global demand for respirators far
outpaces the ability of the entire industry to deliver," chief executive
Mike Roman said on a conference call.
"That is why as we urgently expand capacity, we are also prioritizing and triaging our supplies to the most critical needs."
Executives
described the overall impact of COVID-19 as "mixed" for 3M, with sales
in several product lines declining due to shutdowns, including oral
care, automotive, aerospace and general industrial.
The company
announced it would cut spending by $350 million to $400 million in the
second quarter and withdrew its full-year profit forecast due to
uncertainty over the macroeconomic outlook.
Roman said 3M
invested in "surge" capacity of N95 masks after the SARS outbreak in the
early 2000s, but that had largely not been tapped until now.
The
company doubled global output of N95 masks to 1.1 billion per year and
was in the process of working with the Defense Department to again
double annual production to 2 billion per year by the end of this year,
he said.
In early April, President Donald Trump slammed 3M for
exporting the N95 masks rather than saving them for the US market. The
company, which strongly rebutted Trump's accusations, later reached an
agreement with the White House to import 166 million respirators, mostly
from a China.
- Fighting fraud -
Roman said the company was working with law enforcement officials to combat predatory practices surrounding the masks.
3M has created a toll-free hotline for consumers with questions about whether products are authentic or to report fraud claims
The
company has also published its prices to combat price-gouging. Company
officials say N95 respirators should typically cost about $1, but that
some outfits are trying to sell them for $10 or more.
Most of the
parties involved in the illicit trade have no relationship with 3M, but
the company has "in a few instances terminated distributors in our
industrial channel for acting unethically or in violation of their
agreements," Roman said.
There has been a surge of cases where authorities are cracking down on firms trying to exploit the crisis.
A
US judge in New York on Friday issued a temporary restraining order
against Performance Supply LLC, a New Jersey company that 3M sued.
3M
said Performance Supply, which is not a company-authorized seller,
offered to sell millions of masks to New York city at "a grossly
inflated" price of about $45 million.
The Securities and Exchange
Commission announced fraud charges Tuesday against Praxsyn Corp., a
Florida company that purported to be a major mask distributor, but never
had possession of any masks.
And US prosecutors in New York on
Monday brought criminal fraud charges against Donald Allen and Manuel
Revolorio of California, who allegedly sought more than $4 million for
personal protective equipment, including N95 masks.
Shares of 3M rose 2.6 percent to finish the day at $157.61.
Comments
Post a Comment